Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study.

Le QT, Kim HE, Schneider CJ, Muraközy G, Skladowski K, Reinisch S, Chen Y, Hickey M, Mo M, Chen MG, Berger D, Lizambri R, Henke M.

J Clin Oncol. 2011 Jul 10;29(20):2808-14. doi: 10.1200/JCO.2010.32.4095. Epub 2011 Jun 13.

PMID:
21670453
2.

Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.

Henke M, Alfonsi M, Foa P, Giralt J, Bardet E, Cerezo L, Salzwimmer M, Lizambri R, Emmerson L, Chen MG, Berger D.

J Clin Oncol. 2011 Jul 10;29(20):2815-20. doi: 10.1200/JCO.2010.32.4103. Epub 2011 Jun 13.

PMID:
21670447
3.

Incidence and risk factors for lower alimentary tract mucositis after 1529 courses of chemotherapy in a homogenous population of oncology patients: clinical and research implications.

Krishna SG, Zhao W, Grazziutti ML, Sanathkumar N, Barlogie B, Anaissie EJ.

Cancer. 2011 Feb 1;117(3):648-55. doi: 10.1002/cncr.25633. Epub 2010 Sep 22.

4.

Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.

Vadhan-Raj S, Trent J, Patel S, Zhou X, Johnson MM, Araujo D, Ludwig JA, O'Roark S, Gillenwater AM, Bueso-Ramos C, El-Naggar AK, Benjamin RS.

Ann Intern Med. 2010 Sep 21;153(6):358-67. doi: 10.7326/0003-4819-153-6-201009210-00003.

PMID:
20855800
5.

Interventions for treating oral mucositis for patients with cancer receiving treatment.

Clarkson JE, Worthington HV, Furness S, McCabe M, Khalid T, Meyer S.

Cochrane Database Syst Rev. 2010 Aug 4;(8):CD001973. doi: 10.1002/14651858.CD001973.pub4. Review.

PMID:
20687070
6.

A deletion polymorphism in glutathione-S-transferase mu (GSTM1) and/or theta (GSTT1) is associated with an increased risk of toxicity after autologous blood and marrow transplantation.

Hahn T, Zhelnova E, Sucheston L, Demidova I, Savchenko V, Battiwalla M, Smiley SL, Ambrosone CB, McCarthy PL Jr.

Biol Blood Marrow Transplant. 2010 Jun;16(6):801-8. doi: 10.1016/j.bbmt.2010.01.001. Epub 2010 Jan 13.

7.

Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients.

Sonis S, Treister N, Chawla S, Demetri G, Haluska F.

Cancer. 2010 Jan 1;116(1):210-5. doi: 10.1002/cncr.24696.

8.

Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy.

Peterson DE, Barker NP, Akhmadullina LI, Rodionova I, Sherman NZ, Davidenko IS, Rakovskaya GN, Gotovkin EA, Shinkarev SA, Kopp MV, Kulikov EP, Moiseyenko VM, Gertner JM, Firsov I, Tuleneva T, Yarosh A, Woon CW.

J Clin Oncol. 2009 Sep 10;27(26):4333-8. doi: 10.1200/JCO.2008.21.2381. Epub 2009 Jul 27.

PMID:
19636011
9.

Nutritional support for head and neck cancer patients receiving radiotherapy: a systematic review.

Garg S, Yoo J, Winquist E.

Support Care Cancer. 2010 Jun;18(6):667-77. doi: 10.1007/s00520-009-0686-3. Epub 2009 Jul 7. Review.

PMID:
19582484
10.

The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents.

Sankhala K, Mita A, Kelly K, Mahalingam D, Giles F, Mita M.

Target Oncol. 2009 Apr;4(2):135-42. doi: 10.1007/s11523-009-0107-z. Epub 2009 Apr 21. Review.

PMID:
19381454
11.

Mucositis and non-invasive markers of small intestinal function.

Tooley KL, Howarth GS, Butler RN.

Cancer Biol Ther. 2009 May;8(9):753-8. Epub 2009 May 19. Review.

PMID:
19276675
12.

Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life.

Elting LS, Keefe DM, Sonis ST, Garden AS, Spijkervet FK, Barasch A, Tishler RB, Canty TP, Kudrimoti MK, Vera-Llonch M; Burden of Illness Head and Neck Writing Committee.

Cancer. 2008 Nov 15;113(10):2704-13. doi: 10.1002/cncr.23898.

13.

Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group.

Schwab M, Zanger UM, Marx C, Schaeffeler E, Klein K, Dippon J, Kerb R, Blievernicht J, Fischer J, Hofmann U, Bokemeyer C, Eichelbaum M; German 5-FU Toxicity Study Group.

J Clin Oncol. 2008 May 1;26(13):2131-8. doi: 10.1200/JCO.2006.10.4182. Epub 2008 Feb 25.

PMID:
18299612
14.

Pathobiology of oral mucositis: novel insights and opportunities.

Sonis ST.

J Support Oncol. 2007 Oct;5(9 Suppl 4):3-11. Review.

PMID:
18046993
15.

Phase I study of paclitaxel and uracil plus tegafur combination in patients with pretreated metastatic breast cancer: drug sequencing based on preclinical modelling studies.

Passardi A, Maltoni R, Milandri C, Cecconetto L, Massa I, Zoli W, Tesei A, Fabbri F, Nanni O, Amadori D.

Oncology. 2007;72(1-2):118-24. Epub 2007 Nov 15.

PMID:
18004083
16.

Interventions for preventing oral mucositis for patients with cancer receiving treatment.

Worthington HV, Clarkson JE, Eden OB.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD000978. Review. Update in: Cochrane Database Syst Rev. 2010;(12):CD000978.

PMID:
17943748
17.

Methotrexate-induced mucositis in acute leukemia patients is not associated with the MTHFR 677T allele in Mexico.

Ruiz-Argüelles GJ, Coconi-Linares LN, Garcés-Eisele J, Reyes-Núñez V.

Hematology. 2007 Oct;12(5):387-91.

PMID:
17891601
18.

Measurement of oral mucositis in children: a review of the literature.

Tomlinson D, Judd P, Hendershot E, Maloney AM, Sung L.

Support Care Cancer. 2007 Nov;15(11):1251-8. Epub 2007 Aug 28. Review.

PMID:
17724620
19.

Updated clinical practice guidelines for the prevention and treatment of mucositis.

Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE; Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology.

Cancer. 2007 Mar 1;109(5):820-31.

20.

Mucosal injury from targeted anti-cancer therapy.

Keefe DM, Gibson RJ.

Support Care Cancer. 2007 May;15(5):483-90. Epub 2006 Nov 14. Review.

PMID:
17103195

Supplemental Content

Support Center